Anti-BPI antibodies against both the N- and the C-terminal domains isolated from IBD patient sera were able to inhibit bactericidal activity of BPI, and were associated with a more aggressive disease in IBD [78]. The gene discussed is BPI; the disease is inflammatory bowel disease.